NCT01981213

Brief Summary

A: Early predictors of hepatic injury after suicide attempt with acetaminophen: To explore the following in a pediatric population with acetaminophen overdose due to suicide attempt: 1) the prevalence of episodes of pre- and in-hospital vomiting and the relationship between the total number of vomiting episodes and hepatic injury, 2) the relevance of the early initiation of N-acetylcysteine (NAC) treatment to hepatic injury, and 3) the presence/absence of illness prior to the suicide attempt and hepatic injury. B: Characteristics, social behaviour, trends and risk factors: 1\. To explore the relationship between children admitted to a paediatric department as a result of suicide attempts with acetaminophen and their parents and friends. 2. To determine the extent to which the children had attempted to speak to their parents or other adults about their problems before their suicide attempts. 3. To determine the prevalence of self-mutilation among children with suicidal behaviour. 4. To examine the reasons for these suicide attempts. C: Establishment of the expression of cytochrome P450 in a pediatric including the age-adjusted activities. Urine samples will be analyzed using an HPLC tandem mass spectrometric method, which we have already established in our lab. There will be categorized three groups for comparison:

  1. 1.An age-appropriate background population (approximately 200 patients)
  2. 2.Paediatric patients that have been admitted to Rigshospitalet, due to severe hepatic injury (approximately 50 patients)
  3. 3.Other pediatric patients admitted to their local hospital because of acetaminophen poisoning (approximately 200 patients) A control urine sample will be analyzed three months after the suicide attempt.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2005

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
8.8 years until next milestone

First Submitted

Initial submission to the registry

October 24, 2013

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 11, 2013

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

November 11, 2013

Status Verified

November 1, 2013

Enrollment Period

10.6 years

First QC Date

October 24, 2013

Last Update Submit

November 5, 2013

Conditions

Keywords

AcetaminophenSuicideAttemptsEarly Predictors of Hepatic InjuryChildhood Suicidal Behaviour

Outcome Measures

Primary Outcomes (1)

  • Early predictors of hepatic injury

    1\) To identify early clinical and biochemical predictors of hepatoxicity in children and adolescents after the ingestion of a single acetaminophen overdose as a part of a suicide attempt e.g. pre-hospital vomiting, in-hospital vomiting, stomach pains, latency time before NAC treatment, illness prior to the suicide attempt. The initial and maximum levels of the following biochemical parameters are registered from the electronic biochemistry files of each patient: gluthathione (GLU), basic phosphatase (BP), INR, ALT, AST, and s-acetaminophen.

    2 years

Secondary Outcomes (2)

  • Expression of CYP 1A2 in a pediatric population

    2 years

  • Characteristics, social behaviour, trends and risk factors

    2 years

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pediatric Department, children/adolescents who have tried to commit suicide with acetaminophen (8-18 years-old)

You may qualify if:

  • years-old, who tried to commit suicide with acetaminophen.
  • Children are only included if they have answered all our standard questions.

You may not qualify if:

  • Children with known liver disease prior to the suicide attempt.
  • Suicide attempts with other agents than acetaminophen.
  • Children taking medication that enhance the induction of the cytochrome P450 system, increase the production of toxic metabolites, and aggravate the hepatic injury, such as ethanol, rifampin, isoniazid, barbiturates, and carbamazepine, will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nordsjællands Hospital

Hillerød, 3400, Denmark

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

The initial and maximum levels of the biochemical parameters will be registered from the electronic biochemistry files of each patient: GLU, basic phosphatase (BP), INR, ALT, and AST.

MeSH Terms

Conditions

Suicide

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehavior

Central Study Contacts

Rikke L. Hedeland, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Target Duration
5 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 24, 2013

First Posted

November 11, 2013

Study Start

January 1, 2005

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

November 11, 2013

Record last verified: 2013-11

Locations